BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma-Reference-Cited by-同舟云学术

BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma

Published:2018-01-19 Issue:5 Volume:65 Page:e26947
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Chisholm Julia C.¹^ORCID,Suvada Jozef²,Dunkel Ira J.³,Casanova Michela⁴,Zhang Weijiang⁵,Ritchie Natasha⁶,Choi YounJeong⁷,Park Jane⁷,Das Thakur Meghna⁷,Simko Stephen⁷,Wan Rachel Tam Nga⁷,Ferrari Andrea⁴^ORCID

Affiliation:

1. Children and Young People's Unit; The Royal Marsden NHS Foundation Trust; Sutton UK

2. Department of Pediatric Hematology and Oncology; Children's Teaching Hospital and St. Elizabeth University; Bratislava Slovakia

3. Memorial Sloan Kettering Cancer Center; New York New York

4. Fondazione IRCCS Istituto Nazionale dei Tumori; Milan Italy

5. Roche Innovation Center; New York New York

6. Roche Products Limited; Welwyn Garden City UK

7. Genentech; South San Francisco California

Funder

F. Hoffmann-La Roche

National Institutes of Health

NCI Cancer Center

National Health Service

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference42 articles.

1. Ferlay J Soerjomataram I Ervik M GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No.11. Lyon, France 2013 http://globocan.iarc.fr

2. Pediatric melanoma: Risk factor and survival analysis of the surveillance, epidemiology and end results database;Strouse;J Clin Oncol,2005

3. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma;Navid;Cancer,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma in children: A systematic review and individual patient meta‐analysis;Journal of the European Academy of Dermatology and Venereology;2023-06-02

2. Resistance mechanisms in BRAFV600E paediatric high-grade glioma and current therapeutic approaches;Frontiers in Oncology;2022-12-13

3. Neurology’s vital role in preventing unnecessary and potentially harmful pediatric studies;Expert Review of Neurotherapeutics;2022-03-04

4. The role of systemic therapy in paediatric cutaneous melanoma: a review;Pediatric Medicine;2022-01

5. Cutaneous Melanoma;Pediatric Oncology;2022